Issue Date: June 11, 2012
Boehringer Ingelheim To Build Tech Center
Boehringer Ingelheim will spend more than $62 million to build a facility for producing new active pharmaceutical ingredients at the company’s Biberach, Germany, site. The new facility will make clinical-scale quantities of compounds arising from the firm’s own drug development pipeline. The pilot plant facility will have 15 reactors with volumes from 100 to 300 L and four manufacturing bays, including four synthesis labs for scale-up work. Boehringer expects to complete construction of the plant and associated tech center in early 2014.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society